Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide

Katherine A. Zukotynski, Urban Emmenegger, Sebastien Hotte, Anil Kapoor, Wei Fu, Amanda L. Blackford, John Valliant, François Bénard, Chun K. Kim, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis, Kenneth J. Pienta, Michael A. Gorin, Matthew Lubanovic, Jihyun Kim, Martin G. Pomper, Steve Y. Cho and Steven P. Rowe
Journal of Nuclear Medicine October 2021, 62 (10) 1430-1437; DOI: https://doi.org/10.2967/jnumed.120.259069
Katherine A. Zukotynski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Urban Emmenegger
4Sunnybrook Odette Cancer Centre and Research Institute, University of Toronto, Toronto, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastien Hotte
5Department of Oncology, McMaster University, Hamilton, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anil Kapoor
6Department of Urology, McMaster University, Hamilton, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Fu
7Division of Biostatistics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda L. Blackford
7Division of Biostatistics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Valliant
8Department of Chemistry, McMaster University, Hamilton, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Bénard
9Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada;
10PET Functional Imaging, BC Cancer, Vancouver, British Columbia, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chun K. Kim
11Department of Medicine, Hanyang University College of Medicine, Seoul, South Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark C. Markowski
12Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario A. Eisenberger
12Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmanuel S. Antonarakis
12Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth J. Pienta
13James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Gorin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Lubanovic
1Departments of Radiology and Medicine, McMaster University, Hamilton, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jihyun Kim
15Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin G. Pomper
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Y. Cho
15Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; and
16University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven P. Rowe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 62 no. 10 1430-1437
DOI 
https://doi.org/10.2967/jnumed.120.259069
PubMed 
33608426

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication October 21, 2020
  • Accepted for publication January 27, 2021
  • Published online October 1, 2021.

Article Versions

  • previous version (February 19, 2021 - 13:44).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Katherine A. Zukotynski1–3,
  2. Urban Emmenegger4,
  3. Sebastien Hotte5,
  4. Anil Kapoor6,
  5. Wei Fu7,
  6. Amanda L. Blackford7,
  7. John Valliant8,
  8. François Bénard9,10,
  9. Chun K. Kim11,
  10. Mark C. Markowski12,
  11. Mario A. Eisenberger12,
  12. Emmanuel S. Antonarakis12,
  13. Kenneth J. Pienta13,
  14. Michael A. Gorin12–14,
  15. Matthew Lubanovic1,
  16. Jihyun Kim15,
  17. Martin G. Pomper12–14,
  18. Steve Y. Cho*,15,16 and
  19. Steven P. Rowe*,12–14
  1. 1Departments of Radiology and Medicine, McMaster University, Hamilton, Ontario, Canada;
  2. 2Department of Medical Imaging, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada;
  3. 3Department of Radiology, University of British Columbia, Vancouver, BC;
  4. 4Sunnybrook Odette Cancer Centre and Research Institute, University of Toronto, Toronto, Ontario, Canada;
  5. 5Department of Oncology, McMaster University, Hamilton, Ontario, Canada;
  6. 6Department of Urology, McMaster University, Hamilton, Ontario, Canada;
  7. 7Division of Biostatistics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland;
  8. 8Department of Chemistry, McMaster University, Hamilton, Ontario, Canada;
  9. 9Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada;
  10. 10PET Functional Imaging, BC Cancer, Vancouver, British Columbia, Canada;
  11. 11Department of Medicine, Hanyang University College of Medicine, Seoul, South Korea;
  12. 12Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland;
  13. 13James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
  14. 14Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland;
  15. 15Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; and
  16. 16University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
  1. For correspondence or reprints, contact Steven P. Rowe (srowe8{at}jhmi.edu).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 36 Citations
  • 35 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
    Wolfgang P. Fendler, Matthias Eiber, Mohsen Beheshti, Jamshed Bomanji, Jeremie Calais, Francesco Ceci, Steve Y. Cho, Stefano Fanti, Frederik L. Giesel, Karolien Goffin, Uwe Haberkorn, Heather Jacene, Phillip J. Koo, Klaus Kopka, Bernd J. Krause, Liza Lindenberg, Charles Marcus, Felix M. Mottaghy, Daniela E. Oprea-Lager, Joseph R. Osborne, Morand Piert, Steven P. Rowe, Heiko Schöder, Simon Wan, Hans-Jürgen Wester, Thomas A. Hope, Ken Herrmann
    European Journal of Nuclear Medicine and Molecular Imaging 2023 50 5
  • [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
    Louise Emmett, Shalini Subramaniam, Megan Crumbaker, Andrew Nguyen, Anthony M Joshua, Andrew Weickhardt, Sze-Ting Lee, Siobhan Ng, Roslyn J Francis, Jeffrey C Goh, David A Pattison, Thean Hsiang Tan, Ian D Kirkwood, Craig Gedye, Natalie K Rutherford, Shahneen Sandhu, Aravind Ravi Kumar, David Pook, Shakher Ramdave, David P Nadebaum, Mark Voskoboynik, Andrew D Redfern, William Macdonald, Laurence Krieger, Geoff Schembri, Wei Chua, Peter Lin, Lisa Horvath, Patricia Bastick, Patrick Butler, Alison Yan Zhang, Sonia Yip, Hayley Thomas, Ailsa Langford, Michael S Hofman, Margaret McJannett, Andrew James Martin, Martin R Stockler, Ian D Davis
    The Lancet Oncology 2024 25 5
  • PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature
    Pierpaolo Alongi, Riccardo Laudicella, Helena Lanzafame, Andrea Farolfi, Paola Mapelli, Maria Picchio, Irene A. Burger, Andrei Iagaru, Fabio Minutoli, Laura Evangelista
    Cancers 2022 14 7
  • Prostate-specific Membrane Antigen Reporting and Data System Version 2.0
    Rudolf A. Werner, Philipp E. Hartrampf, Wolfgang P. Fendler, Sebastian E. Serfling, Thorsten Derlin, Takahiro Higuchi, Kenneth J. Pienta, Andrei Gafita, Thomas A. Hope, Martin G. Pomper, Matthias Eiber, Michael A. Gorin, Steven P. Rowe
    European Urology 2023 84 5
  • ENZA‐p trial protocol: a randomized phase II trial using prostate‐specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration‐resistant prostate cancer treated with enzalutamide (ANZUP 1901)
    Louise Emmett, Shalini Subramaniam, Anthony M. Joshua, Megan Crumbaker, Andrew Martin, Alison Y. Zhang, Nisha Rana, Ailsa Langford, Jenna Mitchell, Sonia Yip, Roslyn Francis, Michael S. Hofman, Shahneen Sandhu, Arun Azad, Craig Gedye, Margaret McJannett, Martin R. Stockler, Ian D. Davis
    BJU International 2021 128 5
  • PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors
    Qaid Ahmed Shagera, Ioannis Karfis, Paulus Kristanto, Sideris Spyridon, Romain Diamand, Albert Santapau, Alexandre Peltier, Thierry Roumeguère, Patrick Flamen, Carlos Artigas
    Journal of Nuclear Medicine 2023 64 12
  • Non-invasive PD-L1 quantification using [18F]DK222-PET imaging in cancer immunotherapy
    Akhilesh Mishra, Kuldeep Gupta, Dhiraj Kumar, Gabriela Lofland, Ajay Kumar Sharma, Lilja B Solnes, Steven P Rowe, Patrick M Forde, Martin G Pomper, Edward W Gabrielson, Sridhar Nimmagadda
    Journal for ImmunoTherapy of Cancer 2023 11 10
  • [18F]DCFPyL PET/CT for Imaging of Prostate Cancer
    Steven P. Rowe, Andreas Buck, Ralph A. Bundschuh, Constantin Lapa, Sebastian E. Serfling, Thorsten Derlin, Takahiro Higuchi, Michael A. Gorin, Martin G. Pomper, Rudolf A. Werner
    Nuklearmedizin - NuclearMedicine 2022 61 03
  • Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT
    Patrick W. Mihatsch, Matthias Beissert, Martin G. Pomper, Thorsten A. Bley, Anna K. Seitz, Hubert Kübler, Andreas K. Buck, Steven P. Rowe, Sebastian E. Serfling, Philipp E. Hartrampf, Rudolf A. Werner
    Cancers 2022 14 2
  • Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor–Directed Molecular Imaging and Therapy
    Sebastian E. Serfling, Philipp E. Hartrampf, Yingjun Zhi, Takahiro Higuchi, Steven P. Rowe, Lena Bundschuh, Markus Essler, Andreas K. Buck, Ralph Alexander Bundschuh, Rudolf A. Werner
    Clinical Nuclear Medicine 2022 47 6

Article usage

Article usage: March 2021 to April 2025

AbstractFullPdf
Feb 20211572082
Mar 2021692061
Apr 2021478018
May 202120303
Jun 2021279011
Jul 202113107
Aug 2021209019
Sep 2021100036
Oct 202110264069
Nov 20214011642
Dec 20214641219
Jan 2022445620
Feb 2022387924
Mar 2022350626
Apr 20226621332
May 20223523423
Jun 20222127833
Jul 20223634829
Aug 20222922229
Sep 20221330217
Oct 20222321321
Nov 2022237915
Dec 20221638512
Jan 20232139923
Feb 20231935025
Mar 20231536113
Apr 20231123415
May 2023722721
Jun 20231120111
Jul 2023626110
Aug 2023633410
Sep 20231223512
Oct 2023613011
Nov 20232211719
Dec 2023135510
Jan 20241317913
Feb 20242620016
Mar 2024615038
Apr 202496220
May 2024153318
Jun 202485222
Jul 202468025
Aug 2024136425
Sep 202492625
Oct 202482623
Nov 2024112320
Dec 202473817
Jan 202514821
Feb 2025117431
Mar 2025113822
Apr 2025106338
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (10)
Journal of Nuclear Medicine
Vol. 62, Issue 10
October 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
Katherine A. Zukotynski, Urban Emmenegger, Sebastien Hotte, Anil Kapoor, Wei Fu, Amanda L. Blackford, John Valliant, François Bénard, Chun K. Kim, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis, Kenneth J. Pienta, Michael A. Gorin, Matthew Lubanovic, Jihyun Kim, Martin G. Pomper, Steve Y. Cho, Steven P. Rowe
Journal of Nuclear Medicine Oct 2021, 62 (10) 1430-1437; DOI: 10.2967/jnumed.120.259069

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
Katherine A. Zukotynski, Urban Emmenegger, Sebastien Hotte, Anil Kapoor, Wei Fu, Amanda L. Blackford, John Valliant, François Bénard, Chun K. Kim, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis, Kenneth J. Pienta, Michael A. Gorin, Matthew Lubanovic, Jihyun Kim, Martin G. Pomper, Steve Y. Cho, Steven P. Rowe
Journal of Nuclear Medicine Oct 2021, 62 (10) 1430-1437; DOI: 10.2967/jnumed.120.259069
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • Results
    • Discussion
    • Conclusion
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

Keywords

  • antiandrogen
  • response assessment
  • CRPC
  • radiopharmaceutical
  • prognosis
SNMMI

© 2025 SNMMI

Powered by HighWire